Page 48 - Boxed Warning News Today

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced the...

Highland Therapeutics Announces Appointment of Stephanie C. Read as President/CEO, Changes to Board of Directors - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced the...

/PRNewswire/ -- Neurelis, Inc., a neuroscience-based company dedicated to enhancing therapeutic benefits and addressing significant unmet needs in managing...

BASEL, Switzerland and NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer (NYSE: PFE) announced today an update on the...

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International...

- Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI in Patients Early in Illness - DUBLIN, April 7, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented

The FDA has approved Tlando (testosterone undecanoate), an oral testosterone replacement therapy for adult males.

The FDA has approved Tlando (testosterone undecanoate), an oral testosterone replacement therapy for adult males.

Press release content from Business Wire. The AP news staff was not involved in its creation.